VivaGel condoms on sale at Woolworths: Starpharma
Starpharma (ASX:SPL) has revealed that condoms using its VivaGel antimicrobial gel are now available in Australian stores.
Condom developer Ansell has launched its LifeStyles Dual Protect brand condoms, the first with an antiviral agent, in Woolworths stores across Australia.
The products use both Ansell’s and Starpharma’s VivaGel branding, and Starpharma will receive royalties based on sales.
“This product is a great example of a globally significant innovation developed and commercialised by two Australian companies,” Starpharma CEO Dr Jackie Fairley said. “Consumer interest in the product has been high and the remarkable interest seen on social media bears this out.”
Starpharma also revealed it has received a $4.2 million R&D tax incentive refund covering its spending for the year ending in June.
The refund covers spending on Starpharma’s VivaGel and DEP docetaxel programs. VivaGel is also developing a VivaGel product for the prevention of recurrent bacterial vaginosis (BV) and is trialling DEP docetaxel in a range of solid tumours.
Starpharma recently completed an $18 million placement to help fund these clinical programs and will wrap up an up to $5 million share purchase plan at close of business Wednesday.
The company revealed it has so far received applications for more than 65% of the total offer. Any shortfall may be placed with institutional investors.
Starpharma (ASX:SPL) shares were trading 2.72% higher at $0.642 as of around 1.30 pm on Wednesday.
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
